Disabling hearing loss and ear infections
There are around 360 million individuals (5.3% of the global population) worldwide suffering from disabling hearing loss.
60% of global disabling hearing loss is preventable and treatable with early detection and interventions. More than half of this is caused by untreated ear infections or loud noises, cerumen impaction and the use of ototoxic medicines.
Over 90% of the burden of chronic ear infections is borne by low and middle income countries, partly due to lack of available human resources.
Affordable and sustainable hearing and ear care solutions need to be implemented into these countries to help resolve resource shortages. Digital healthcare and telehealth is highly effective way of tackling this problem.
Cupris’s solution can bring significant benefits to emerging countries by:
Increasing patient access to healthcare services, especially in remote areas with limited accessibility
Cutting the timing, costs and inconvenience of travelling several miles to access care
Allowing healthcare professionals to deal with more patients
Improving training programmes for local healthcare professionals
It is a cost-effective and sustainable method for providing healthcare and treating hearing loss and ear conditions in remote areas.
We have been working with charities and NGOs to trial our solution in Malawi and Nepal.
USE CASE - NEPAL PILOT STUDY
In March 2016, Rishi Mandavia, a UK ENT Trainee spent 2 days at a rural hospital in Nepal, a country with a very high prevalence of ear disease, with 16.6% and 7.4% of the total population having hearing impairment and eardrum pathology respectively.
He examined 52 patients and recorded images and patient's otological history through Cupris device and software. This data was assessed remotely a few months later by a Consultant-grade UK ENT Surgeon. Another UK trained ENT Consultant Surgeon was present in the rural Nepalese hospital and performed a face-to-face consultation, considered as the standard assessment. Diagnosis and treatment plans were compared.
The results were published in Clinical Otolaryngology and showed a concordance of
95% in diagnosis
100% in the decision as to whether a patient warranted further evaluation and treatment.
We are now looking at ways to expand our solution all over the developing world to enable anyone to access healthcare and prevent hearing loss caused by untreated ear infections.